tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

PRLD Stock Latest News

Prelude Therapeutics presents first interim data from trial of PRT2527
The FlyPrelude Therapeutics presents first interim data from trial of PRT2527
17d ago
PRLD
Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities
PremiumThe Fly
Prelude Therapeutics price target lowered to $4 from $7 at JMP Securities
17d ago
PRLD
Prelude Therapeutics Reports Progress in Clinical Trials and Financial Health
PremiumCompany Announcements
Prelude Therapeutics Reports Progress in Clinical Trials and Financial Health
1M ago
PRLD
Prelude Therapeutics Shows Strong Q3 2024 Financial Results
PremiumCompany Announcements
Prelude Therapeutics Shows Strong Q3 2024 Financial Results
2M ago
8K
PRLD
Prelude Therapeutics reports Q3 EPS (43c), consensus (47c)
PremiumThe Fly
Prelude Therapeutics reports Q3 EPS (43c), consensus (47c)
2M ago
PRLD
Prelude Therapeutics price target lowered to $1 from $3 at Barclays
PremiumThe FlyPrelude Therapeutics price target lowered to $1 from $3 at Barclays
2M ago
PRLD
Prelude Therapeutics presents new data from Phase 1 trial of PRT3789
Premium
The Fly
Prelude Therapeutics presents new data from Phase 1 trial of PRT3789
2M ago
PRLD
Prelude announces publication of abstracts on SMARCA Degrader Programs
Premium
The Fly
Prelude announces publication of abstracts on SMARCA Degrader Programs
3M ago
PRLD
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
PremiumThe Fly
Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
3M ago
T
ME
Five Below downgraded, DoorDash upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Five Below downgraded, DoorDash upgraded: Wall Street’s top analyst calls
3M ago
ABT
CAR
Prelude Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe Fly
Prelude Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
3M ago
PRLD
Prelude Therapeutics reports results from Phase 1 trial of PRT3789
PremiumThe Fly
Prelude Therapeutics reports results from Phase 1 trial of PRT3789
4M ago
PRLD
Prelude Therapeutics Unveils Promising Cancer Treatment Data at ESMO
PremiumCompany AnnouncementsPrelude Therapeutics Unveils Promising Cancer Treatment Data at ESMO
4M ago
8K
PRLD
Prelude Therapeutics announces publication of abstract on PRT3789
Premium
The Fly
Prelude Therapeutics announces publication of abstract on PRT3789
4M ago
PRLD
Prelude Therapeutics Unveils Strategic Insights for Investors
Premium
Company Announcements
Prelude Therapeutics Unveils Strategic Insights for Investors
5M ago
8K
PRLD
Prelude Therapeutics reports Q2 EPS (46c), consensus (43c)
PremiumThe Fly
Prelude Therapeutics reports Q2 EPS (46c), consensus (43c)
5M ago
PRLD
Prelude Therapeutics announces clinical collaboration with Merck
PremiumThe Fly
Prelude Therapeutics announces clinical collaboration with Merck
6M ago
MRK
PRLD
AI Could Revolutionize Drug Discovery: A Look at Key Players 
PremiumMarket News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
6M ago
GS
TAK
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
6M ago
KR
ACI
Spirit Aero downgraded, Skyworks upgraded: Wall Street’s top analyst calls
PremiumThe FlySpirit Aero downgraded, Skyworks upgraded: Wall Street’s top analyst calls
6M ago
BA
BFH
Prelude Therapeutics downgraded to Underweight from Equal Weight at Barclays
Premium
The Fly
Prelude Therapeutics downgraded to Underweight from Equal Weight at Barclays
6M ago
PRLD
Prelude Therapeutics Unveils Educational SMARCA Series
Premium
Company Announcements
Prelude Therapeutics Unveils Educational SMARCA Series
7M ago
8K
PRLD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >